Mechanisms of resistance to ABL kinase inhibition in CML and the development of next generation ABL kinase inhibitors

Eitemau Tebyg

• BCR-ABL1 compound mutations in tyrosine kinase inhibitor–resistant CML: frequency and clonal relationships
  gan: Khorashad, Jamshid S., et al.
  Cyhoeddwyd: (2013)
• Mechanisms of Resistance to the BCR-ABL1 Allosteric Inhibitor Asciminib
  gan: Qiang, Wang, et al.
  Cyhoeddwyd: (2017)
• Kinase Inhibitor Therapy in CML: It's What's Inside That Counts
  gan: Eide, Christopher A., et al.
  Cyhoeddwyd: (2013)
• Radotinib is an Effective Inhibitor of Native and Kinase Domain-Mutant BCR-ABL1
  gan: Zabriskie, Matthew S., et al.
  Cyhoeddwyd: (2015)
• Blockade of JAK2-mediated extrinsic survival signals restores sensitivity of CML cells to ABL inhibitors
  gan: Traer, Elie, et al.
  Cyhoeddwyd: (2011)